Improving the Quality of Life of Latin American Patients
M8 provides healthcare professionals and patients with access to proven treatments they need to thrive. We serve as a comprehensive source of expertise in each of the following therapeutic areas.
Central Nervous System
- Atarax®(Hydroxyzine)
- Concerta®(Methylphenidate)
- Mokbio®(Lactobacillus plantarum 128)
- Haldol®(Haloperidol )
- Lexotan®(Bromazepam)
- Nabota®(Botulinum Toxin type A)
- Razapina®(Mirtazapina)
- Reminyl®(Galantamine Bromhide)
- Risperdal®(Risperidone)
- Seroquel®(Quetiapine)
- Sibelium®(Flunarizine)
- Topamax®(Topiramate)
- Nootropil®(Piracetam)
- Valium®(Diazepam)
- Diacomit®(Stiripentol)
Cardiometabolism
Oncology & Hematology
Reliable, Convenient Service and Support for Professionals and Patients
Partner with Us
From go-to-market strategy and registration to access and long-term market presence, M8 is a purpose-built biopharmaceutical platform that supports the entire development-commercialization continuum.
Our Commitment to Latin America
Six core values guide us on our mission to provide support to the patients and healthcare professionals of Latin America.
Diacomit®
Generic: Stiripentol
Description
Epilepsy: – Simple or complex partial seizures (with or without loss of consciousness) with or without secondary generalization. – Generalized tonic-clonic seizures. Mixed forms of seizures. It is suitable for both monotherapy and add-on therapy.